Point72 Hong Kong LTD Pacira Bio Sciences, Inc. Transaction History

Point72 Hong Kong LTD

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $139,331 - $220,917	-2,706 Reduced 77.45%	788 $46,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $104,812 - $133,551	1,746 Added 99.89%	3,494 $267,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $79,438 - $103,019	1,656 Added 1800.0%	1,748 $105,000
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $356,799 - $400,289	-6,530 Reduced 98.61%	92 $5,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $391,889 - $463,473	6,622 New	6,622 $402,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $50,235 - $66,760	-847 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $42,748 - $56,122	847 New	847 $51,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $140,630 - $170,478	-2,706 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $83,344 - $141,983	2,706 New	2,706 $142,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $44,988 - $58,022	-1,239 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $26,210 - $33,067	735 Added 145.83%	1,239 $47,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $18,029 - $23,649	493 Added 4481.82%	504 $22,000
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $401 - $463	11 New	11 $0
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $2,956 - $4,680	-90 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $6,352 - $9,193	-231 Reduced 71.96%	90 $3,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $29 - $46	-1 Reduced 0.31%	321 $10,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $6,752 - $9,953	212 Added 192.73%	322 $15,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $3,927 - $4,345	110	110 $4,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.